Trial Details

TERMINATED
Basic Information
Clinical ID c1572
Identifier NCT04859075
Trial Title Efficacy and Safety of Alflorex Bei Reizdarm in Patients With Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions OTHER: Bifidobacterium longum 35624
Participant Information
Sponsor Medice Arzneimittel Pütter GmbH & Co KG
City North Rhine-Westphalia
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2021-05-05
Primary Completion Date 2021-11-09
Completion Date 2021-11-09